Hologic Inc. (HOLX)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS

250 CAMPUS DRIVE MARLBOROUGH, MA 01752

Hologic Inc. develops, manufactures and supplies diagnostic and medical imaging systems primarily serving the healthcare needs of women. Customers include hospitals, imaging clinics and private practices, many of the leading healthcare organizations in the world and major pharmaceutical companies.

Data as of 2020-07-04
Market Cap14.94 Billion Shares Outstanding258.206 Million Avg 30-day Volume2.727 Million
P/E Ratio33.9 Dividend Yield EPS1.68
Price/Sales6.042 Price cash flow ratio23.7 Price free cash flow ratio32.2
Book Value8.08 Price to Tangible Book-8.02 Alpha-0.0
Short Interest Ratio % Short Interest to Float R-squared0.508132
BETA1.4579 52-week High/Low58.72 / 26.49 Stddev0.087095
View SEC Filings from HOLX instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 4 3 (0.2%)
13F Filers holding this stock: 464 107 (7.01%)
Aggregate 13F shares on 03/31/2020: 237.401 Million 89.342 Million
Aggregate 13F shares on 12/31/2019: 250.526 Million 95.528 Million
Percent change: -5.24% -6.48%
Funds creating new positions: 59 19
Funds Adding to an existing position: 162 39
Funds closing out their position: 88 30
Funds reducing their position: 174 41
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding HOLX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HOLX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

66.8 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

34.9 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STAMOULIS CHRISTIANA EVP & CHIEF FINANCIAL OFFICER

  • Officer
21,067 2020-07-02 2

VALENTI PETER J. III DIVISION PRES., BREAST HEALTH

  • Officer
59,991 2020-06-30 5

ICAHN CARL C

  • 10% Owner
  • CHAIRMAN OF THE BOARD
205,063,328 2020-06-25 0

MUIR GLENN P

  • Director
0 2020-06-11 0

CHRISTODORO JONATHAN

62,257 2020-06-08 0

LEAMING NANCY

  • Director
12,988 2020-06-03 0

WENDELL AMY MCBRIDE

  • Director
0 2020-06-01 1

CRAWFORD SALLY

  • Director
29,498 2020-05-28 3

ICAHN CARL C

HIGH RIVER LIMITED PARTNERSHIP

ICAHN PARTNERS LP

ICAHN PARTNERS MASTER FUND LP

  • 10% Owner
0 2020-05-26 0

KINGSLEY STUART A

  • Director
0 2020-05-20 0

THORNAL KEVIN R DIV. PRESIDENT, DIAGNOSTICS

  • Officer
17,026 2020-05-15 5

COUGHLIN CHRISTOPHER J

  • Director
39,656 2020-05-14 0

MACMILLAN STEPHEN P CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
1,722,442 2020-05-13 5

MERKSAMER SAMUEL J.

  • Director
0 2020-05-08 0

DOCKENDORFF CHARLES J

  • Director
73,203 2020-05-07 1

GARRETT SCOTT T

  • Director
51,385 2020-05-01 2

GRIFFIN JOHN M. GENERAL COUNSEL

  • Officer
95,307 2020-04-28 5

CASEY MARK J EVP AND CHIEF LEGAL OFFICER

  • Officer
47,302 2020-04-01 0

HANTSON LUDWIG CEO

  • Officer
  • Director
190,658 2020-03-30 1

WEST THOMAS A. PRESIDENT AND CEO

236,890 2020-03-17 0

NAWANA NAMAL

  • Director
13,713 2020-03-05 1

WILSON WAYNE

  • Director
91,012 2020-03-02 0

OBERTON KARLEEN MARIE CHIEF FINANCIAL OFFICER

  • Officer
28,956 2020-01-02 3

COHN BENJAMIN JORDAN PRINCIPAL ACCOUNTING OFFICER

  • Officer
18,162 2019-12-04 4

BEBO ALLISON P SVP, HUMAN RESOURCES

  • Officer
28,389 2019-12-01 2

MCMAHON ROBERT W. SR. VP AND CFO

  • Officer
51,659 2019-11-19 0

LEVANGIE DANIEL J

  • Director
12,458 2019-07-31 0

CUMMING JOHN W

  • Director
23,580 2019-06-11 0

ULLIAN ELAINE

  • Director
0 2019-06-01 0

SULLIVAN PATRICK J

  • Director
30,580 2019-04-30 0

COMPTON ERIC B. COO

  • Officer
107,560 2017-12-01 0

LEVY LAWRENCE M

  • Director
32,615 2017-10-10 0

HARDING DAVID CHIEF COMMERCIAL OFFICER

  • Officer
0 2017-02-09 0

LAVANCE DAVID R JR

  • Director
9,362 2016-02-24 0

STEIN JAY A CHIEF TECHNICAL OFFICER

  • Officer
201,648 2015-11-18 0

EGSTRAND CLAUS SVP AND GM, INTERNATIONAL

  • Officer
3,150 2015-11-05 0

DORAN HOWARD JR PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2014-11-20 0

MILLS ROGER D. GSVP & GM SERVICE & OPERATIONS

  • Officer
58,823 2014-11-07 0

HASTIE ROHAN GROUP SVP & GM DIAGNOSTICS

  • Officer
2,857 2014-08-06 0

LAVALLEE ROBERT H SVP, CHIEF ACCOUNTING OFFICER

  • Officer
11,341 2014-05-06 0

BRADY DAVID J SVP, HUMAN RESOURCES

  • Officer
0 2013-11-18 0

CASCELLA ROBERT CEO AND PRESIDENT

  • Officer
  • Director
401,438 2013-07-01 0

SOLTANI PETER SVP & GM, WOMEN'S HEALTH

  • Officer
42,625 2013-06-28 0

HULL CARL SVP AND GM OF DIAGNOSTICS

  • Officer
61,674 2013-02-01 0

WILLIAMSON STEVE S SVP, GYN SURGICAL

  • Officer
41,721 2012-03-07 0

MYSLINSKI MARK D SVP, DIAGNOSTICS

  • Officer
0 2011-01-31 0

PEKARSKY JOHN R SVP, SALES & STRATEGIC ACCOUNT

  • Officer
No longer subject to file 2010-06-28 0

MCDANIEL C WILLIAM

  • Director
63,660 2008-06-13 0

LERNER ARTHUR G

  • Director
No longer subject to file 2008-01-07 0

FAJARDO LAURIE

  • Director
No longer subject to file 2008-01-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

VALENTI PETER J. III - Officer DIVISION PRES., BREAST HEALTH

2020-06-30 S 10,493 $54.07 d 59,991 59,991.00 direct yes

VALENTI PETER J. III - Officer DIVISION PRES., BREAST HEALTH

2020-06-30 M 10,493 $26.21 a 70,484 59,991.00 direct yes

VALENTI PETER J. III - Officer DIVISION PRES., BREAST HEALTH

2020-06-30 M 10,493 d 0 59,991.00 direct yes

VALENTI PETER J. III - Officer DIVISION PRES., BREAST HEALTH

2020-05-22 M 10,493 d 10,493 59,991.00 direct

VALENTI PETER J. III - Officer DIVISION PRES., BREAST HEALTH

2020-05-22 S 10,493 $51.82 d 59,991 59,991.00 direct

CRAWFORD SALLY - Director

2020-05-22 S 31,950 $51.99 d 126,847 126,847.00 direct

VALENTI PETER J. III - Officer DIVISION PRES., BREAST HEALTH

2020-05-22 M 10,493 $26.21 a 70,484 59,991.00 direct

THORNAL KEVIN R - Officer DIV. PRESIDENT, DIAGNOSTICS

2020-05-15 M 13,888 $26.01 a 30,914 17,026.00 direct

THORNAL KEVIN R - Officer DIV. PRESIDENT, DIAGNOSTICS

2020-05-15 M 13,888 d 0 17,026.00 direct

THORNAL KEVIN R - Officer DIV. PRESIDENT, DIAGNOSTICS

2020-05-15 S 13,888 $51.51 d 17,026 17,026.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments